Research Article
Epidemiology of Neonatal Sepsis and Implicated Pathogens: A Study from Egypt
Table 5
Distribution of bacterial isolates according to the global sensitivities.
| | Antibiotics | Global resistances (%) | Gram-positive cocci resistances (%) () | Gram-negative resistances (%) () |
| | Ampicillin | 122 (96.06) | 70 (95.89) | 52 (96.30) | | Oxacillin | — | 64 (87.67) | NT | | Amoxicillin-clavulanic acid | 86 (67.72) | 37 (50.68) | 49 (90.74) | | Cefoxitin | 106 (83.46) | 64 (87.67) | 42 (77.78) | | Cefotaxime | 92 (72.44) | 43 (58.90) | 49 (90.74) | | Ceftriaxone | 92 (72.44) | 43 (58.90) | 49 (90.74) | | Ceftazidime | 115 (90.55) | 69 (94.52) | 46 (85.19) | | Imipenem | 28 (22.05) | 12 (16.44) | 16 (29.63) |
| | Vancomycin | — | 0 (0) | NT |
| | Gentamicin | 78 (61.42) | 42 (57.53) | 36 (66.67) | | Amikacin | 50 (39.37) | 13 (17.81) | 37 (68.52) |
| | Erythromycin | — | 45 (61.64) | NT | | Azithromycin | — | 45 (61.64) | NT |
| | Ciprofloxacin | 43 (33.86) | 22 (30.14) | 21 (38.89) | | Norfloxacin | 44 (34.65) | 22 (30.14) | 22 (40.74) |
|
|
NT: not tested.
|
